Icotyde psoriasis launch is expected to drive J&J’s growth across indications. Discover the potential impact and future plans.
UK approval for insulin unit marks a significant milestone for Biocon Malaysia.
Aurobindo Pharma inhaler approval brings positive news for the company and patients alike. Discover the details here.
